{
    "2021-12-21": [
        [
            {
                "time": "",
                "original_text": "北向资金交投意愿转淡连续3日净卖出，白酒、新能源均遭出货",
                "features": {
                    "keywords": [
                        "北向资金",
                        "交投意愿",
                        "转淡",
                        "净卖出",
                        "白酒",
                        "新能源"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "小摩增持泰格医药(03347)8.34万股，每股作价约120.60港元",
                "features": {
                    "keywords": [
                        "小摩",
                        "增持",
                        "泰格医药",
                        "8.34万股",
                        "120.60港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【首发】百因诺生物完成近2亿元A轮融资，加大CDMO和无血清细胞培养基的研发及生产平台建设投入",
                "features": {
                    "keywords": [
                        "百因诺生物",
                        "A轮融资",
                        "2亿元",
                        "CDMO",
                        "无血清细胞培养基",
                        "研发",
                        "生产平台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}